Vivani Medical (VANI) Competitors

$1.18 +0.02 (+1.29%)

As of 01:51 PM Eastern

VANI vs. COCH, DCTH, CLPT, CV, and SI

Should you buy Vivani Medical stock or one of its competitors? MarketBeat compares Vivani Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Vivani Medical include Envoy Medical (COCH), Delcath Systems (DCTH), ClearPoint Neuro (CLPT), CapsoVision (CV), and Shoulder Innovations (SI). These companies are all part of the "medical equipment" industry.

How does Vivani Medical compare to Envoy Medical?

Envoy Medical (NASDAQ:COCH) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 6.8% of Vivani Medical shares are held by institutional investors. 7.1% of Envoy Medical shares are held by company insiders. Comparatively, 53.3% of Vivani Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Vivani Medical has a net margin of 0.00% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-9,875.64%	N/A	-177.92%
Vivani Medical	N/A	-264.04%	-79.85%

Envoy Medical currently has a consensus price target of $6.00, suggesting a potential upside of 748.66%. Vivani Medical has a consensus price target of $3.50, suggesting a potential upside of 197.87%. Given Envoy Medical's stronger consensus rating and higher probable upside, equities analysts plainly believe Envoy Medical is more favorable than Vivani Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Vivani Medical had 2 more articles in the media than Envoy Medical. MarketBeat recorded 3 mentions for Vivani Medical and 1 mentions for Envoy Medical. Vivani Medical's average media sentiment score of 1.53 beat Envoy Medical's score of 0.30 indicating that Vivani Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envoy Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Vivani Medical	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Envoy Medical has a beta of 1.92, meaning that its stock price is 92% more volatile than the broader market. Comparatively, Vivani Medical has a beta of 2.35, meaning that its stock price is 135% more volatile than the broader market.

Envoy Medical has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$240K	226.48	-$23.76M	-$1.01	N/A
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A

Summary

Envoy Medical beats Vivani Medical on 8 of the 15 factors compared between the two stocks.

How does Vivani Medical compare to Delcath Systems?

Vivani Medical (NASDAQ:VANI) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation.

Vivani Medical presently has a consensus price target of $3.50, indicating a potential upside of 197.87%. Delcath Systems has a consensus price target of $22.50, indicating a potential upside of 100.18%. Given Vivani Medical's higher probable upside, research analysts clearly believe Vivani Medical is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43

Delcath Systems has a net margin of 0.62% compared to Vivani Medical's net margin of 0.00%. Delcath Systems' return on equity of 0.51% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-264.04%	-79.85%
Delcath Systems	0.62%	0.51%	0.46%

In the previous week, Vivani Medical and Vivani Medical both had 3 articles in the media. Vivani Medical's average media sentiment score of 1.53 beat Delcath Systems' score of 0.00 indicating that Vivani Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vivani Medical	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Delcath Systems	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Delcath Systems has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A
Delcath Systems	$85.23M	4.55	$2.70M	$0.01	1,124.00

6.8% of Vivani Medical shares are held by institutional investors. Comparatively, 61.1% of Delcath Systems shares are held by institutional investors. 53.3% of Vivani Medical shares are held by company insiders. Comparatively, 19.4% of Delcath Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Vivani Medical has a beta of 2.35, suggesting that its stock price is 135% more volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market.

Summary

Delcath Systems beats Vivani Medical on 10 of the 14 factors compared between the two stocks.

How does Vivani Medical compare to ClearPoint Neuro?

ClearPoint Neuro (NASDAQ:CLPT) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and institutional ownership.

ClearPoint Neuro has higher revenue and earnings than Vivani Medical. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$36.97M	9.38	-$25.54M	-$1.01	N/A
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A

ClearPoint Neuro has a beta of 1.29, suggesting that its stock price is 29% more volatile than the broader market. Comparatively, Vivani Medical has a beta of 2.35, suggesting that its stock price is 135% more volatile than the broader market.

30.1% of ClearPoint Neuro shares are owned by institutional investors. Comparatively, 6.8% of Vivani Medical shares are owned by institutional investors. 6.9% of ClearPoint Neuro shares are owned by company insiders. Comparatively, 53.3% of Vivani Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Vivani Medical has a net margin of 0.00% compared to ClearPoint Neuro's net margin of -71.57%. ClearPoint Neuro's return on equity of -140.96% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-71.57%	-140.96%	-36.98%
Vivani Medical	N/A	-264.04%	-79.85%

ClearPoint Neuro presently has a consensus target price of $18.00, indicating a potential upside of 55.66%. Vivani Medical has a consensus target price of $3.50, indicating a potential upside of 197.87%. Given Vivani Medical's higher probable upside, analysts plainly believe Vivani Medical is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, ClearPoint Neuro had 2 more articles in the media than Vivani Medical. MarketBeat recorded 5 mentions for ClearPoint Neuro and 3 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 1.53 beat ClearPoint Neuro's score of -0.02 indicating that Vivani Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ClearPoint Neuro	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Vivani Medical	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

ClearPoint Neuro beats Vivani Medical on 8 of the 15 factors compared between the two stocks.

How does Vivani Medical compare to CapsoVision?

CapsoVision (NASDAQ:CV) and Vivani Medical (NASDAQ:VANI) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability.

In the previous week, Vivani Medical had 2 more articles in the media than CapsoVision. MarketBeat recorded 3 mentions for Vivani Medical and 1 mentions for CapsoVision. Vivani Medical's average media sentiment score of 1.53 beat CapsoVision's score of 0.00 indicating that Vivani Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CapsoVision	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Vivani Medical	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

CapsoVision currently has a consensus price target of $8.50, suggesting a potential upside of 26.02%. Vivani Medical has a consensus price target of $3.50, suggesting a potential upside of 197.87%. Given Vivani Medical's higher possible upside, analysts plainly believe Vivani Medical is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

CapsoVision has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than CapsoVision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CapsoVision	$13.55M	24.87	-$25.32M	-$2.34	N/A
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A

6.8% of Vivani Medical shares are held by institutional investors. 2.3% of CapsoVision shares are held by company insiders. Comparatively, 53.3% of Vivani Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Vivani Medical has a net margin of 0.00% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CapsoVision	-198.87%	N/A	-136.03%
Vivani Medical	N/A	-264.04%	-79.85%

Summary

Vivani Medical beats CapsoVision on 8 of the 14 factors compared between the two stocks.

How does Vivani Medical compare to Shoulder Innovations?

Shoulder Innovations (NYSE:SI) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

Vivani Medical has a net margin of 0.00% compared to Shoulder Innovations' net margin of -81.78%. Shoulder Innovations' return on equity of -35.11% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-81.78%	-35.11%	-20.58%
Vivani Medical	N/A	-264.04%	-79.85%

In the previous week, Vivani Medical had 1 more articles in the media than Shoulder Innovations. MarketBeat recorded 3 mentions for Vivani Medical and 2 mentions for Shoulder Innovations. Vivani Medical's average media sentiment score of 1.53 beat Shoulder Innovations' score of 0.38 indicating that Vivani Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shoulder Innovations	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Vivani Medical	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Vivani Medical has lower revenue, but higher earnings than Shoulder Innovations. Vivani Medical is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	6.52	-$40.36M	-$166.96	N/A
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A

Shoulder Innovations presently has a consensus target price of $21.00, indicating a potential upside of 41.08%. Vivani Medical has a consensus target price of $3.50, indicating a potential upside of 197.87%. Given Vivani Medical's higher probable upside, analysts plainly believe Vivani Medical is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

6.8% of Vivani Medical shares are owned by institutional investors. 29.0% of Shoulder Innovations shares are owned by company insiders. Comparatively, 53.3% of Vivani Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Vivani Medical beats Shoulder Innovations on 8 of the 14 factors compared between the two stocks.

Get Vivani Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VANI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VANI vs. The Competition

Export

Metric	Vivani Medical	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$101.33M	$3.02B	$6.38B	$12.34B
Dividend Yield	N/A	1.96%	2.79%	5.33%
P/E Ratio	-2.94	17.77	20.91	25.65
Price / Sales	N/A	301.47	543.80	85.61
Price / Cash	N/A	57.57	44.13	56.16
Price / Book	5.34	4.59	10.09	7.06
Net Income	-$26.61M	$74.99M	$3.55B	$335.04M
7 Day Performance	0.43%	0.14%	4.71%	2.60%
1 Month Performance	-11.65%	-4.86%	1.43%	1.42%
1 Year Performance	3.07%	35.48%	36.72%	35.67%

Vivani Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VANI Vivani Medical	3.8559 of 5 stars	$1.18 +1.3%	$3.50 +197.9%	+2.7%	$101.33M	N/A	N/A	20	News Coverage Positive News Insider Trade
COCH Envoy Medical	1.978 of 5 stars	$0.66 -2.8%	$6.00 +807.7%	-54.2%	$50.82M	$240K	N/A	34	Positive News
DCTH Delcath Systems	1.7864 of 5 stars	$11.59 +2.2%	$22.50 +94.2%	-33.6%	$400.47M	$85.23M	1,160.10	60
CLPT ClearPoint Neuro	2.0106 of 5 stars	$12.08 -4.4%	$18.00 +49.0%	-3.8%	$362.46M	$36.97M	N/A	110
CV CapsoVision	1.0723 of 5 stars	$6.95 -2.8%	$8.50 +22.3%	N/A	$346.46M	$13.55M	N/A	90	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:VANI) was last updated on 5/22/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Vivani Medical (VANI) Competitors

VANI vs. COCH, DCTH, CLPT, CV, and SI

How does Vivani Medical compare to Envoy Medical?

Summary

How does Vivani Medical compare to Delcath Systems?

Summary

How does Vivani Medical compare to ClearPoint Neuro?

Summary

How does Vivani Medical compare to CapsoVision?

Summary

How does Vivani Medical compare to Shoulder Innovations?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VANI vs. The Competition

Vivani Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Vivani Medical (VANI) Competitors

VANI vs. COCH, DCTH, CLPT, CV, and SI

How does Vivani Medical compare to Envoy Medical?

Do institutionals & insiders hold more shares of COCH or VANI?

Is COCH or VANI more profitable?

Do analysts rate COCH or VANI?

Does the media refer more to COCH or VANI?

Which has more risk and volatility, COCH or VANI?

Which has preferable valuation & earnings, COCH or VANI?

Summary

How does Vivani Medical compare to Delcath Systems?

Do analysts prefer VANI or DCTH?

Is VANI or DCTH more profitable?

Does the media prefer VANI or DCTH?

Which has higher valuation and earnings, VANI or DCTH?

Do institutionals and insiders have more ownership in VANI or DCTH?

Which has more risk and volatility, VANI or DCTH?

Summary

How does Vivani Medical compare to ClearPoint Neuro?

Which has stronger valuation and earnings, CLPT or VANI?

Which has more volatility & risk, CLPT or VANI?

Do institutionals & insiders have more ownership in CLPT or VANI?

Is CLPT or VANI more profitable?

Do analysts rate CLPT or VANI?

Does the media favor CLPT or VANI?

Summary

How does Vivani Medical compare to CapsoVision?

Does the media favor CV or VANI?

Do analysts prefer CV or VANI?

Which has higher earnings and valuation, CV or VANI?

Do insiders & institutionals hold more shares of CV or VANI?

Is CV or VANI more profitable?

Summary

How does Vivani Medical compare to Shoulder Innovations?

Is SI or VANI more profitable?

Does the media prefer SI or VANI?

Which has higher valuation & earnings, SI or VANI?

Do analysts recommend SI or VANI?

Do insiders and institutionals have more ownership in SI or VANI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VANI vs. The Competition

Vivani Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools